Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiptor in CP/CPPS
NCT03500159Phase 2Terminated
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rosiglitazone in chronic prostatitis (CP), chronic pelvic pain syndrome (CPPS), sponsored by Aquinox Pharmaceuticals. Started Apr 2018; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT03500159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500159.